Your browser doesn't support javascript.
loading
Healthcare costs related to adverse events in hepatocellular carcinoma treatment: A retrospective observational claims study.
Lal, Lincy S; Aly, Abdalla; Le, Lisa B; Peckous, Susan; Seal, Brian; Teitelbaum, April.
Affiliation
  • Lal LS; Health Economics and Outcomes Research, Optum, Eden Prairie, Minnesota, USA.
  • Aly A; US Medical Affairs, AstraZeneca, Gaithersburg, Maryland, USA.
  • Le LB; Health Economics and Outcomes Research, Optum, Eden Prairie, Minnesota, USA.
  • Peckous S; Health Economics and Outcomes Research, Optum, Eden Prairie, Minnesota, USA.
  • Seal B; US Medical Affairs, AstraZeneca, Gaithersburg, Maryland, USA.
  • Teitelbaum A; Hematology Oncology Associates, San Diego, California, USA.
Cancer Rep (Hoboken) ; 5(5): e1504, 2022 05.
Article in En | MEDLINE | ID: mdl-34494389
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Hepatocellular / Liver Neoplasms Type of study: Health_economic_evaluation / Observational_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male Country/Region as subject: America do norte Language: En Journal: Cancer Rep (Hoboken) Year: 2022 Document type: Article Affiliation country: United States Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Hepatocellular / Liver Neoplasms Type of study: Health_economic_evaluation / Observational_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male Country/Region as subject: America do norte Language: En Journal: Cancer Rep (Hoboken) Year: 2022 Document type: Article Affiliation country: United States Country of publication: United States